Vismederi Holding
  • Home
  • Vismederi Holding
  • News
  • Contact
  • English
  • Italian
Select Page
VisMederi Foundation: Continuing its Commitment to Social Welfare by Supporting Piccolo Principe and Danilo Nannini Foundation

VisMederi Foundation: Continuing its Commitment to Social Welfare by Supporting Piccolo Principe and Danilo Nannini Foundation

by VH102021 | Jul 23, 2023 | News&events

The VisMederi Foundation demonstrates its commitment to the most vulnerable groups, strengthening its ties with the Siena territory and actively supporting projects for social solidarity. The Foundation proudly presented a contribution certificate to the associations...
VisMederi Receives Prestigious Certificate from The Coalition for Epidemic Preparedness Innovations (CEPI)

VisMederi Receives Prestigious Certificate from The Coalition for Epidemic Preparedness Innovations (CEPI)

by VH102021 | Jul 17, 2023 | News&events

We are delighted to share the exciting news that VisMederi has been honored with a prestigious certificate from The Coalition for Epidemic Preparedness Innovations (CEPI)! CEPI, a foundation that collaborates with public, private, philanthropic, and civil society...
Neutralizing antibody responses against the Respiratory Syncytial Virus

Neutralizing antibody responses against the Respiratory Syncytial Virus

by VH102021 | Jul 7, 2023 | News&events

New paper dissecting the neutralizing antibody responses against the Respiratory Syncytial Virus; a new approach to virus neutralization assay validation and future application in clinical studies. Published on the “Journal of medical virology” Link to...

Articoli recenti

  • A new scientific publication from VisMederi has recently been published in Influenza and Other Respiratory Viruses.
  • VisMederi announces the successful qualification of a standardized, high-throughput Luminescence Serum Bactericidal Assay (L-SBA)
  • Bundibugyo ebolavirus: supporting vaccine development for an emerging public health threat
  • VisMederi Expands Its Service Portfolio with End-to-End Sample Kit Management
  • VisMederi and CEVAC Sign Memorandum of Understanding to Strengthen Vaccine Clinical Trial Capabilities in Europe

Commenti recenti

No comments to show.

Archivi

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • January 2024
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • May 2023
  • December 2022
  • November 2022
  • September 2022
  • June 2022
  • May 2022
  • March 2022
  • October 2021
  • August 2018
  • October 2017
  • May 2017
  • March 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • January 2016
  • October 2015
  • July 2015
  • May 2015
  • January 2015
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • November 2013
  • September 2013
  • April 2013

Categorie

  • News&events
  • Press Review
  • Senza categoria
  • VisMederi
  • Facebook
  • X
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress